Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 3Phase 1 1

Status

Completed 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5Thoracic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Breast Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Biopsy, Needle × Breast × Clear all
NCT03546686 2026-03-27

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

University of Texas Southwestern Medical Center

Phase 2 Active not recruiting
51 enrolled
Breast

Breast Neoplasms

NCT04009044 2025-10-09

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Northwestern University

Phase 2 Active not recruiting
156 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT00482755 2024-02-12

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Canadian Cancer Trials Group

Phase 2 Completed
4 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00665457 2023-09-13

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

University of Nebraska

Phase 2 Terminated
3 enrolled 6 charts
Breast

Breast Neoplasms

NCT00194779 2018-03-12

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

University of Washington

Phase 2 Completed
50 enrolled 13 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡